COVID-19 and fatigue: Where do we go from here? Response to Ortelli et al.

被引：0
作者：
Conti, Isabella [1 ]
Cross, Benjamin [2 ]
Rooney, Alasdair G. [3 ]
Nicholson, Timothy R. [4 ]
机构：
[1] Queens Univ Belfast, Sch Med, Belfast, Antrim, North Ireland
[2] East Lancashire Hosp NHS Trust, Burnley, Lancs, England
[3] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland
[4] Inst Psychiat, Sect Cognit Neuropsychiat, London, England
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 426卷
关键词：
COVID-19; Neuropsychiatry; Neurophysiology;
D O I：
10.1016/j.jns.2021.117470
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here
    Halperin, Daniel T.
    Hearst, Norman
    Hodgins, Stephen
    Bailey, Robert C.
    Klausner, Jeffrey D.
    Jackson, Helen
    Wamai, Richard G.
    Ladapo, Joseph A.
    Over, Mead
    Baral, Stefan
    Escandon, Kevin
    Gandhi, Monica
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [32] Coronavirus (COVID-19) and stress: Where do we stand in this journey and where are we leading to!
    Avinash, Bhagyalakshmi
    Sadashivamurthy, Prashanth
    Shivamallu, Avinash Bettahalli
    Ali, Irfan
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2022, 14 : 1087 - 1089
  • [33] Prevention and Control of Coronavirus Disease 2019: Where Do We Go From Here?
    Neuzil, Kathleen M.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E692 - E694
  • [34] How Did We Get Here and Where Do We Go From Here?: Supporting Undocumented Students Through a Pandemic
    DeLuca-Acconi, Robin
    Bessaha, Melissa
    Velazquez, Suzanne L.
    Mendoza, Mario R.
    SCHOOL PSYCHOLOGY, 2022, 37 (02) : 202 - 211
  • [35] Deciphering Vaccines for COVID-19: where do we stand today?
    Baviskar, Tushar
    Raut, Dezaree
    Bhatt, Lokesh Kumar
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2021, 43 (01) : 8 - 21
  • [36] Laboratory biomarkers and prognosis in Covid-19, where do we stand?
    Israni, Alisha
    Goulden, Christopher J.
    Harky, Amer
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (06)
  • [37] COVID-19 pandemic and cardiovascular disease: where do we stand?
    Chatzis, Dimitrios G.
    Magounaki, Kalliopi T.
    Pantazopoulos, Ioannis N.
    Johnson, Elizabeth O.
    Tsioufis, Konstantinos P.
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (04): : 347 - 358
  • [38] Directly Acting Antivirals for COVID-19: Where Do We Stand?
    Teoh, Siew L.
    Lim, Yi H.
    Lai, Nai M.
    Lee, Shaun W. H.
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [39] COVID-19 after 18 months: Where do we stand?
    Chassagnon, Guillaume
    Regarda, Lucile
    Soyera, Philippe
    Revel, Marie-Pierre
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2021, 102 (09) : 491 - 492
  • [40] Strengthening regulatory systems for medicines in a changed world: where do we go from here?
    O'Brien, Julie
    Lumsden, Rebecca
    Macdonald, Judith
    BMJ GLOBAL HEALTH, 2021, 6 (01):
12345